RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Maia Biotechnology Stock

Maia Biotechnology ROCE 2024

Maia Biotechnology ROCE

-42.27

Ticker

MAIA

ISIN

US5526411021

In 2024, Maia Biotechnology's return on capital employed (ROCE) was -42.27, a 2,122.95% increase from the -1.9 ROCE in the previous year.

Maia Biotechnology Aktienanalyse

What does Maia Biotechnology do?

Maia Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Maia Biotechnology's Return on Capital Employed (ROCE)

Maia Biotechnology's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Maia Biotechnology's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Maia Biotechnology's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Maia Biotechnology’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Maia Biotechnology stock

What is the ROCE (Return on Capital Employed) of Maia Biotechnology this year?

The ROCE of Maia Biotechnology is -42.27 undefined this year.

How has the ROCE (Return on Capital Employed) of Maia Biotechnology developed compared to the previous year?

The ROCE of Maia Biotechnology has increased by 2,122.95% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Maia Biotechnology?

A high Return on Capital Employed (ROCE) indicates that Maia Biotechnology has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Maia Biotechnology?

A low ROCE (Return on Capital Employed) can indicate that Maia Biotechnology has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Maia Biotechnology impact the company?

An increase in the ROCE of Maia Biotechnology can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Maia Biotechnology affect the company?

A decrease in ROCE of Maia Biotechnology can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Maia Biotechnology?

Some factors that can affect Maia Biotechnology's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Maia Biotechnology so important for investors?

The ROCE of Maia Biotechnology is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Maia Biotechnology take to improve the ROCE?

To improve the ROCE, Maia Biotechnology can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Maia Biotechnology pay?

Over the past 12 months, Maia Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Maia Biotechnology is expected to pay a dividend of 0 USD.

What is the dividend yield of Maia Biotechnology?

The current dividend yield of Maia Biotechnology is .

When does Maia Biotechnology pay dividends?

Maia Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Maia Biotechnology?

Maia Biotechnology paid dividends every year for the past 0 years.

What is the dividend of Maia Biotechnology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Maia Biotechnology located?

Maia Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Maia Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Maia Biotechnology from 11/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.

When did Maia Biotechnology pay the last dividend?

The last dividend was paid out on 11/4/2024.

What was the dividend of Maia Biotechnology in the year 2023?

In the year 2023, Maia Biotechnology distributed 0 USD as dividends.

In which currency does Maia Biotechnology pay out the dividend?

The dividends of Maia Biotechnology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Maia Biotechnology

Our stock analysis for Maia Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Maia Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.